Lack of bronchial beta adrenoceptor resistance in asthmatics during long-term treatment with terbutaline.

[1]  S. Larsson,et al.  Development of "resistance" in beta-adrenergic receptors of asthmatic patients. , 1976, Chest.

[2]  N. Svedmyr,et al.  Evaluation of skeletal muscle tremor due to bronchodilator agents. , 1975, Scandinavian journal of respiratory diseases.

[3]  B. Burrows,et al.  Pulmonary terms and symbols. A report of the ACCP-STS Joint Committee on Pulmonary Nomenclature. , 1975, Chest.

[4]  S. Ayres,et al.  Bronchial component in chronic obstructive lung disease. , 1974, The American journal of medicine.

[5]  R. Reisman,et al.  Asthma induced by adrenergic aerosols. , 1970, Chest.

[6]  J. Fleisch,et al.  The prevention of isoproterenol desensitization and isoproterenol reversal. , 1972, The Journal of pharmacology and experimental therapeutics.

[7]  C. Dollery,et al.  Resistance to β‐adrenoceptor stimulants (a possible explanation for the rise in asthma deaths) , 1971, British journal of pharmacology.

[8]  M. Rand,et al.  Bronchodilator effects of sympathomimetic amines given singly and in combination. , 1971, European journal of pharmacology.

[9]  N. Svedmyr,et al.  The effects of salbutamol and isoprenaline on beta-receptors in patients with chronic obstructive lung disease. , 1971, Postgraduate medical journal.

[10]  A M Adelstein,et al.  Rise and fall of asthma mortality in England and Wales in relation to use of pressurised aerosols. , 1969, Lancet.

[11]  Eisenstadt Ws,et al.  The adverse effect of adrenergic aerosols in bronchial asthma. , 1969 .

[12]  I. Caplin,et al.  Complications of aerosol therapy in asthma. , 1969, Annals of allergy.

[13]  R Doll,et al.  Observations on recent increase in mortality from asthma. , 1968, British medical journal.

[14]  J. Keighley.  Iatrogenic asthma associated with adrenergic aerosols. , 1966, Annals of internal medicine.

[15]  B. Gandevia,et al.  Forced Expiratory Volume before and after Isoprenaline , 1957, Thorax.